Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keizo Kanasaki

Showing results (1-10 of 183) with videos related to

Pageof 19
Sort By:
Journal of Diabetes Investigation|January 31, 2020
N-acetyl-seryl-aspartyl-lysyl-proline is a valuable endogenous antifibrotic peptide for kidney fibrosis in diabetes: An update and translational aspectsKeizo Kanasaki
Diabetology International|January 4, 2019
The pathological significance of dipeptidyl peptidase-4 in endothelial cell homeostasis and kidney fibrosisKeizo Kanasaki
Kidney International|January 26, 2016
Concerted efforts to combat diabetic complicationsKeizo Kanasaki
Clinical Science (London, England : 1979)|January 17, 2019
Correction: The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptinKeizo Kanasaki
Kidney International|November 19, 2023
The aberrant glycolysis in kidney proximal tubule: potential therapeutic target for DKDKeizo Kanasaki
Clinical Science (London, England : 1979)|March 2, 2018
The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptinKeizo Kanasaki
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 21, 2025
Expanding the therapeutic frontier: esaxerenone in hypertensive patients with CKD and albuminuriaKeizo Kanasaki
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 13, 2024
Risk of preeclampsia in pregnant individuals with chronic kidney disease: a framework from Chinese cohortKeizo Kanasaki
Nihon Jinzo Gakkai Shi|December 16, 2015
[Kidney fibrosis and endothelial injury]Keizo Kanasaki
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 15, 2022
Nutrient-derived modification of mineral corticoid receptors is relevant to diabetic kidney disease progressionKeizo Kanasaki
Pageof 19

Showing results (1-10 of 183) with videos related to

Sort By:
Pageof 19
Journal of Diabetes Investigation|January 31, 2020
N-acetyl-seryl-aspartyl-lysyl-proline is a valuable endogenous antifibrotic peptide for kidney fibrosis in diabetes: An update and translational aspectsKeizo Kanasaki
Diabetology International|January 4, 2019
The pathological significance of dipeptidyl peptidase-4 in endothelial cell homeostasis and kidney fibrosisKeizo Kanasaki
Kidney International|January 26, 2016
Concerted efforts to combat diabetic complicationsKeizo Kanasaki
Clinical Science (London, England : 1979)|January 17, 2019
Correction: The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptinKeizo Kanasaki
Kidney International|November 19, 2023
The aberrant glycolysis in kidney proximal tubule: potential therapeutic target for DKDKeizo Kanasaki
Clinical Science (London, England : 1979)|March 2, 2018
The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptinKeizo Kanasaki
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 21, 2025
Expanding the therapeutic frontier: esaxerenone in hypertensive patients with CKD and albuminuriaKeizo Kanasaki
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 13, 2024
Risk of preeclampsia in pregnant individuals with chronic kidney disease: a framework from Chinese cohortKeizo Kanasaki
Nihon Jinzo Gakkai Shi|December 16, 2015
[Kidney fibrosis and endothelial injury]Keizo Kanasaki
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 15, 2022
Nutrient-derived modification of mineral corticoid receptors is relevant to diabetic kidney disease progressionKeizo Kanasaki
Pageof 19